KLRA · Kailera Therapeutics, Inc.
$17.46
-0.86 (-4.69%)
At close · Aug 20
Market Cap
$2.38B
Shares
129.64M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$17.46
Open$18.20
Day$17.17–18.37
Available close range$16.74–26.00
Avg vol 30d513K
Short int6.6M · 5.1% float · 13.2d
Short vol51%
Last earningsAug 12, 2026
DataApr 2026–Aug 2026
Filing10-Q · Aug 12
The closing range uses available history since Apr 17, 2026; less than a full year is stored.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 12, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Limited
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−9%
below
RSI (14)
42
neutral
MACD trend
Positive
52-week position
8%
near low
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+98 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
5.11% of float · ▲ +3.3% MoM · 13.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
98 holders — 13F breadth
Squeeze score
57
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
64%
annualized · 1-yr
Max drawdown
−36%
past year
ATR
6.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−9%
Bearish
RSI (14)
42
Neutral
MACD trend
Positive
Bullish
52-week position
8%
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+98 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
5.11% of float · ▲ +3.3% MoM · 13.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
98 holders — 13F breadth
Price context
position in its available closing range
Range low $17
Now $17 · 8%
Range high $26
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KLRA
this stock
Kailera Therapeutics, Inc.
|
$2.38B | — | — | — | 5.1% |
|
ONC
BeOne Medicines Ltd.
|
$557.05B | +21.5% | +22179.2% | 856.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +19.2% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.39B | +7.1% | +20.8% | 20.8 | 3.3% |
|
MRNA
Moderna, Inc.
|
$69.62B | +352.1% | +4.3% | — | 12.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KLRA | -2.8% | +0.3% | — | +3.1% | — |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | -0.9% | -3.0% | — | +1.0% | — |
Key facts
CIK
2096997
CUSIP
482931102
13F (30d)
98 filings
96 filers
Visit website
Investor relations